Cash on Hand as of September 2024 : ยฃ0.12 Billion
According to Taysha Gene Therapies's latest financial reports the company has ยฃ0.12 Billion in cash and cash equivalents. A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)